You lost me on that one jacmar. I'm not counting on a MANF partner in 2014, I'd be happy with an orphan designation in Q1 2015. I'd also be happy if Gerald does something "concrete" regarding our LymPro relationship, but I've given up on the hope of a JV with large up front cash.
I'm not the one "spinning" AMBS saying we may not need a RS before up listing. I've been the one saying we'll probably be in the .20 cent range in December, with Chris telling me I'm way, way too conservative.
I'm not the "spinner" here.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links